Prevalence of the HR2 Haplotype in Family Members With (DVT+) or Without (DVT−) VT, According to Their Inherited Thrombophilic Defect
| . | Naturally Occurring Anticoagulant Deficiency . | Factor V R506Q . | Prothrombin G20210A . | Double Defect . | ||||
|---|---|---|---|---|---|---|---|---|
| DVT+ . | DVT− . | DVT+ . | DVT− . | DVT+ . | DVT− . | DVT+ . | DVT− . | |
| HR2+ | 1/11 (9%) | 10/31 (32%) | 4/22 (18%) | 19/239 (8%) | 0/6 (0%) | 16/118 (14%) | 1/8 (13%) | 1/33 (3%) |
| . | Naturally Occurring Anticoagulant Deficiency . | Factor V R506Q . | Prothrombin G20210A . | Double Defect . | ||||
|---|---|---|---|---|---|---|---|---|
| DVT+ . | DVT− . | DVT+ . | DVT− . | DVT+ . | DVT− . | DVT+ . | DVT− . | |
| HR2+ | 1/11 (9%) | 10/31 (32%) | 4/22 (18%) | 19/239 (8%) | 0/6 (0%) | 16/118 (14%) | 1/8 (13%) | 1/33 (3%) |